Journals / ANKEM Dergisi / 2007 / Cilt: 21 - Sayı: 2

ESBL investigation in enterobacteriaceae strains isolated from various clinical samples by DDST and vitek2 methods

Çeşitli klinik örneklerden izole edilen enterobacteriaceae suşlarında GSBL oluşturmanın ÇDST ve VITEK2 yöntemleri ile araştırılması

Pages
71–75
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When compared to the result of DDST, the sensitivity of Vitek2 system was calculated as 100 % and the specificity as 94.1 %.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Extended-spectrum beta-lactamase (ESBL) production by 212 Escherichia coli, 71 Klebsiella spp., 28 Proteus spp. and 10 Enterobacter spp. strains isolated in our hospital was prospectively investigated by double disk synergy test (DDST) and Vitek2 GN13 cards system.
📊
Key Findings & Data:ESBL positivity was detected by DDST and Vitek2 system in E.coli strains as 49 % and 51 %, in Klebsiella spp. strains as 44 % and 51 %, respectively.
💡
Conclusion & Impact:When compared to the result of DDST, the sensitivity of Vitek2 system was calculated as 100 % and the specificity as 94.1 %.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Extended-spectrum beta-lactamase (ESBL) production by 212 Escherichia coli, 71 Klebsiella spp., 28 Proteus spp. and 10 Enterobacter spp. strains isolated in our hospital was prospectively investigated by double disk synergy test (DDST) and Vitek2 GN13 cards system. ESBL positivity was detected by DDST and Vitek2 system in E.coli strains as 49 % and 51 %, in Klebsiella spp. strains as 44 % and 51 %, respectively. GSBL production was not detected in Proteus spp. and Enterobacter spp. strains. High ratio of GSBL production was found in E.coli strains in our hospital. When compared to the result of DDST, the sensitivity of Vitek2 system was calculated as 100 % and the specificity as 94.1 %.

Özet

Nisan 2006-Ağustos 2006 arasında hastanemizde çeşitli klinik örneklerden izole edilen 212 Escherichia coli, 71 Klebsiella spp., 28 Proteus spp. ve 10 Enterobacter spp. olmak üzere toplam 321 suşun GSBL enzimi çift disk sinerji testi (ÇDST) ile ve Vitek2 (bioMérieux) cihazında GN13 kartları ile prospektif olarak araştırılmıştır. GSBL oranları ÇDST ve Vitek2 ile sırasıyla E.coli’de % 49 ve % 51, Klebsiella spp.’de % 44 ve % 51 olarak bulunmuştur. Proteus spp. ve Enterobacter spp. suşlarında GSBL tespit edilmemiştir. Hastanemizde E.coli suşlarında oldukça yüksek GSBL enzimi olduğu görülmüştür. Vitek2 GN13 kartları ile GSBL testinin ÇDST’ne göre duyarlılığı % 100, özgüllüğü % 94.1 olarak bulunmuştur.

🔖

Cite This Article

MEHLİ, M., ZER, Y., GAYYURHAN, E. (2007). ESBL investigation in enterobacteriaceae strains isolated from various clinical samples by DDST and vitek2 methods. ANKEM Dergisi, Cilt: 21 - Sayı: 2, 71–75. https://ajindex.com/articles/199536

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bal Ç: Beta-laktamazlar: güncel durum, Flora 2003;8(2):111-23
  2. Bradford PA: Extended-spectrum beta-laktamases in the 21st century: characterization, epidemiology and detection of this important resistance threat, Clin Microbiol Rev 2001;14(4):933-51
  3. Bush K: New beta-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy, Clin Infect Dis 2001;32(7):108-59
  4. Büyükbaba Ö, Aydın D, An¤ Ö: idrar yolu infeksiyonu etkeni Gram negatif çomaklarda genişlemiş spektrumlu beta-laktamazların çift disk sinerji yöntemi ile belirlenmesi, Klimik Derg 1996;9(1):27-30
  5. Datta P, Thakur A, Mishra B, Gupta V: Prevalence of clinical strains resistant to various beta-lactams lactams in tertiary care hospital in India, Jpn J Infect Dis 2004;57(4):14-69
  6. Delialioğlu N, Öcal ND, Emektaş G: Çeşitli klinik örneklerden izole edilen Escherichia coli ve Klebsiella türlerinde genişlemiş spektrumlu beta-laktamaz oranları, ANKEM Derg 2005;19(2):84-7
  7. Derbentli fi, Katranc› H, Nakiboğlu Y: Gram negatif çomaklarda genişlemiş spektrumlu beta-laktamazların belirlenmesinde üç boyutlu yöntem ve çift disk sinerji yönteminin karşılaştırılması, ANKEM Derg 1996;10(1):1-13
  8. Gill VJ, Fedorko DP, Witebsky FG: The clinician and microbiology laboratory, “Mandel GL, Bennet JE, Dolin R (eds): Principles and Practice of Infectious Diseases, 5.baskı” kitabında s.184-221, Churchill Livigstone, Philadelphia (2000)
  9. Ho PL, Tsang DN, Que TL, Ho M, Yuen KY: Comparison of screening methods for detection of extended- spectrum beta-lactamases and their prevalence among E.coli and Klebsiella spacies in Hong Kong, APMIS 2000;108(3):237-40
  10. Jacoby GA, Medeiros AA: More extended-spectrum beta-lactamases, Antimicrob Agents Chemother 1991;35(9):1697-704
  11. Livermore DM, Brown DF: Detection of beta-lactamase-mediated resistance, J Antimicrob Chemother 2001;48(Suppl 1):59-64
  12. Mumcuoğlu i, Gündüz T, Baydur H: Escherichia,Klebsiella ve Proteus suşlarında genişlemiş spektrumlu beta-laktamaz varlığı ve çeşitli antibiyotiklere direnç durumu, ANKEM Derg 2004;18(1):9-11
  13. Özkan Ç, Oldacay M, Erdem G: Hastane infeksiyonu etkeni olarak izole edilen Escherichia coli ve Klebsiella pneumoniae suşlarında genişlemiş spektrumlu beta-laktamaz sıklığı, ANKEM Derg 2002;16(1):65-8
  14. Sanders CC, Barry AL, Washington JA et al: Detection of extended-spectrum beta-lactamase producing members of the family Enterobacteriaceae with Vitek ESBL test, J Clin Microbio